Ligand Pharmaceuticals Inc
NASDAQ:LGND
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ligand Pharmaceuticals Inc
NASDAQ:LGND
|
US |
|
P
|
Pepco Group NV
WSE:PCO
|
UK |
|
Posco Chemical Co Ltd
KRX:003670
|
KR |
|
Mowi ASA
OSE:MOWI
|
NO |
|
Ready Capital Corp
NYSE:RC
|
US |
|
H
|
Hancom Lifecare Inc
KRX:372910
|
KR |
|
Waratah Minerals Ltd
ASX:WTM
|
AU |
|
CTEEP Companhia de Transmissao de Energia Eletrica Paulista
BOVESPA:TRPL4
|
BR |
|
Monarch Cement Co
OTC:MCEM
|
US |
|
T
|
Tobii Dynavox AB
STO:TDVOX
|
SE |
|
J
|
Jyske Bank A/S
LSE:0MGD
|
DK |
|
W
|
WashTec AG
XETRA:WSU
|
DE |
|
MINISO Group Holding Ltd
NYSE:MNSO
|
CN |
|
B
|
Biolog Device Co Ltd
KOSDAQ:208710
|
KR |
|
D
|
Danieli & C Officine Meccaniche SpA
MIL:DAN
|
IT |
|
P
|
Park Systems Corp
KOSDAQ:140860
|
KR |
|
A
|
Alphabet Inc
MIL:GOOG
|
US |
|
Elcora Advanced Materials Corp
F:ELM
|
CA |
|
H
|
Hod Assaf Industries Ltd
TASE:HOD
|
IL |
|
Stonebridge Acquisition Corp
NASDAQ:FAAS
|
US |
|
Sword Group SE
PAR:SWP
|
LU |
|
Hua Hong Semiconductor Ltd
HKEX:1347
|
CN |
|
D
|
Daesung Energy Co Ltd
KRX:117580
|
KR |
|
N
|
Northern Star Investment Corp III
OTC:NSTC
|
US |
Wall Street
Price Targets
LGND Price Targets Summary
Ligand Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
LGND
is 250 USD
with a low forecast of 222.2 USD and a high forecast of 290.85 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is LGND's stock price target?
Price Target
250
USD
According to Wall Street analysts, the average 1-year price target for
LGND
is 250 USD
with a low forecast of 222.2 USD and a high forecast of 290.85 USD.
What is Ligand Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
11%
For the last 14 years the
compound annual growth rate for
Ligand Pharmaceuticals Inc's revenue is
17%.
The projected
CAGR
for the next 3 years is
11%.
What is Ligand Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
59%
For the last 14 years the
compound annual growth rate for
Ligand Pharmaceuticals Inc's operating income is
26%.
The projected
CAGR
for the next 3 years is
59%.
What is Ligand Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
35%
For the last 14 years the
compound annual growth rate for
Ligand Pharmaceuticals Inc's net income is
20%.
The projected
CAGR
for the next 3 years is
35%.
